ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

THMO ThermoGenesis Holdings Inc

0.5501
-0.0213 (-3.73%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 20,556
Bid Price 0.5501
Ask Price 0.5599
News -
Day High 0.5801

Low
0.3606

52 Week Range

High
1.82

Day Low 0.555
Company Name Stock Ticker Symbol Market Type
ThermoGenesis Holdings Inc THMO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0213 -3.73% 0.5501 19:27:44
Open Price Low Price High Price Close Price Prev Close
0.56 0.555 0.5801 0.58 0.5714
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
130 20,556 $ 0.5602248 $ 11,516 - 0.3606 - 1.82
Last Trade Time Type Quantity Stock Price Currency
18:44:25 formt 405 $ 0.5501 USD

ThermoGenesis Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
16.12M 3.14M - 9.45M -17.98M -5.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ThermoGenesis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No THMO Message Board. Create One! See More Posts on THMO Message Board See More Message Board Posts

Historical THMO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.570.8750.540.6343035476,331-0.0199-3.49%
1 Month0.700.8750.520.6293412150,443-0.1499-21.41%
3 Months0.7490.96980.520.656784563,352-0.1989-26.56%
6 Months0.891.250.36060.712592997,795-0.3399-38.19%
1 Year1.181.820.36060.92392576,395-0.6299-53.38%
3 Years125.55141.95250.360614.64639,618-125.00-99.56%
5 Years241.65638.100.360680.31644,463-241.10-99.77%

ThermoGenesis Description

ThermoGenesis Holdings Inc. develops commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking point-of-care applications and automation for immuno-oncology including its semi-automated functionally-closed CAR-TXpress platform which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.

Your Recent History

Delayed Upgrade Clock